Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine: A 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)

OBJECTIVE: When oral therapy for type 2 diabetes is ineffective, adding basal insulin improves glycemic control. However, when glycated hemoglobin (HbA(1c)) remains elevated because of postprandial hyperglycemia, the next therapeutic step is controversial. We examined the efficacy and safety of lixi...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Riddle, Matthew C., Forst, Thomas, Aronson, Ronnie, Sauque-Reyna, Leobardo, Souhami, Elisabeth, Silvestre, Louise, Ping, Lin, Rosenstock, Julio
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Diabetes Association 2013
Θέματα:
Original Research
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3747901/
https://ncbi.nlm.nih.gov/pubmed/23564915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-2462
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια